Top

Published in:

01-04-2017 | Editorial

Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers

Authors: James T. Thackeray, PhD, Frank M. Bengel, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2017

Excerpt

The inherent strength of nuclear cardiology imaging lies in its high sensitivity and capacity for dynamic longitudinal interrogation of evolving (patho)physiologic processes. The ability to monitor molecular changes in the development and resolution of disease is a powerful tool for clinical research and practice. …

Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012;59:153-63.CrossRefPubMedPubMedCentral

Thackeray JT, Derlin T, Haghikia A, Napp LC, Wang Y, Ross TL, et al. Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc Imaging 2015;8:1417-26.CrossRefPubMed

Schatka I, Wollenweber T, Haense C, Brunz F, Gratz KF, Bengel FM. Peptide receptor targeted radionuclide therapy alters inflammation in atherosclerotic plaques. J Am Coll Cardiol 2013;62:2344-5.CrossRefPubMed

Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, et al. 2-Deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis. Nat Med 2014;20:215-9.CrossRefPubMed

Laitinen I, Saraste A, Weidl E, Poethko T, Weber AW, Nekolla SG, et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2009;2:331-8.CrossRefPubMed

Bigalke B, Phinikaridou A, Andia ME, Cooper MS, Schuster A, Schonberger T, et al. Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc. Circ Cardiovasc Imaging 2013;6:957-64.CrossRefPubMed

Golestani R, Razavian M, Nie L, Zhang J, Jung JJ, Ye Y, et al. Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm. Circ Cardiovasc Imaging 2015;8:e002471.CrossRefPubMed

Jin H, Yang H, Liu H, Zhang Y, Zhang X, Rosenberg AJ, et al. A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury. J Nucl Cardiol 2016. doi:10.1007/s12350-015-0391-1.

Blaho VA, Hla T. An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 2014;55:1596-608.CrossRefPubMedPubMedCentral

10.

Swan DJ, Kirby JA, Ali S. Vascular biology: The role of sphingosine 1-phosphate in both the resting state and inflammation. J Cell Mol Med 2010;14:2211-22.CrossRefPubMedPubMedCentral

11.

Wamhoff BR, Lynch KR, Macdonald TL, Owens GK. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2008;28:1454-61.CrossRefPubMedPubMedCentral

12.

Schilson SS, Keul P, Shaikh RS, Schafers M, Levkau B, Haufe G. Synthesis of new ligands for targeting the S1P1 receptor. Bioorg Med Chem 2015;23:1011-26.CrossRefPubMed

13.

Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000;20:335-42.CrossRefPubMed

14.

Thackeray JT, Bankstahl JP, Wang Y, Korf-Klingebiel M, Walte A, Wittneben A, et al. Targeting post-infarct inflammation by PET imaging: Comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model. Eur J Nucl Med Mol Imaging 2015;42:317-27.CrossRefPubMed

15.

Razavian M, Tavakoli S, Zhang J, Nie L, Dobrucki LW, Sinusas AJ, et al. Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation. J Nucl Med 2011;52:1795-802.CrossRefPubMedPubMedCentral

16.

Saraste A, Laitinen I, Weidl E, Wildgruber M, Weber AW, Nekolla SG, et al. Diet intervention reduces uptake of alphavbeta3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques. J Nucl Cardiol 2012;19:775-84.CrossRefPubMed

17.

Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I, et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol 2007;27:2363-9.CrossRefPubMed

Title: Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers
Authors: James T. Thackeray, PhD
Frank M. Bengel, MD
Publication date: 01-04-2017
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 2/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-016-0426-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2017

Simple multimodality imaging: An easy, rapid, and inexpensive approach to improve non-invasive test accuracy

Evaluation of general-purpose collimators against high-resolution collimators with resolution recovery with a view to reducing radiation dose in myocardial perfusion SPECT: A preliminary phantom study

Have SPECT artifacts breathed their last?

The value of local normal limits in quantitative Thallium-201 CZT MPI SPECT

Myocardial perfusion SPECT just keeps getting better and better

Artifacts in Quantitative analysis of myocardial perfusion SPECT, using Cedars-Sinai QPS Software